AACR Annual Meeting 2021 Highlights
Let's Win and the Lustgarten Foundation bring you the pancreatic cancer research highlights of the 2021 AACR Annual Meeting,
Tweeting About Tumors and How Best to Provide Care
Dr. Michael Pishvaian launches #TumorBoardTuesday, a continuing medical education Twitter chat, to discuss patient treatments for GI cancers.
Cachexia Research Gaining Momentum
Why do pancreatic cancer patients lose weight even if they are eating well? Dr. Teresa Zimmers explains the syndrome called cachexia.
Tumor Subtypes Potentially Provide Clues About Prognosis and Treatment
Drs. Andrew Aguirre and David Ting are teasing out the differences between pancreatic cancer subtypes, to get treatments that work better.
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.
AACR Virtual Special Conference on Pancreatic Cancer: Day Two Highlights
Let's Win and the Lustgarten Foundation present highlights of Day Two of the AACR Virtual Special Conference on Pancreatic Cancer.
AACR Virtual Special Conference on Pancreatic Cancer: Day One Highlights
Let's Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
The Future of Pancreatic Cancer Treatment
Dr. Anil Rustgi discusses the latest developments in pancreatic cancer treatment and the direction of current research in early detection.
Targeting Metabolic Vulnerability
Dr. Jordan Winter looks at cell metabolism to find areas of vulnerability in pancreatic cancer cells, to find a way to create better treatments.
What Happens When Pancreatic Cancer Clinical Trials Fail?
These include several potential pancreatic cancer therapies that hit headlines in 2019. Halozyme Therapeutics discontinued the development of PEGylated recombinant…